TCNNF Trulieve Cannabis Corp.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, and Connecticut, as well as directly to patients through home delivery. It produces approximately 155 stock keeping units, including smokable flower, flower pods for vaporizing, concentrates, topicals, capsules, tinctures, and vape cartridges. As of May 05, 2020, the company operated through 49 dispensaries, which included 47 locations in Florida. Trulieve Cannabis Corp. is headquartered in Quincy, Florida.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol CT:TRUL.

$29.15    OTCQX
As of 11/26/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  
IPO date:  09/27/2018
Outstanding shares:  549,195
Average volume:  490,201
Market cap:   $16,305,600
Current dividend yield:  0.00%
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.13
PB ratio:   4.59
PS ratio:   0.02
Return on equity:   15.47%
Net income %:   15.88%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy